Compare SHG & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHG | BNTX |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | South Korea | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9B | 24.2B |
| IPO Year | 2003 | 2019 |
| Metric | SHG | BNTX |
|---|---|---|
| Price | $66.88 | $97.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $133.46 |
| AVG Volume (30 Days) | 293.3K | ★ 966.8K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.16 | N/A |
| Revenue Next Year | $3.88 | $3.37 |
| P/E Ratio | $9.79 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.28 | $79.81 |
| 52 Week High | $73.40 | $124.00 |
| Indicator | SHG | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.00 | 64.21 |
| Support Level | $65.55 | $95.13 |
| Resistance Level | $69.88 | $112.93 |
| Average True Range (ATR) | 1.42 | 2.32 |
| MACD | -0.14 | 0.91 |
| Stochastic Oscillator | 60.84 | 87.63 |
Shinhan Financial Group Co Ltd is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.